Correction to: Exploratory Prognostic Biomarkers of Complement-Mediated Thrombotic Microangiopathy (CM-TMA) in Adults with Atypical Hemolytic Uremic Syndrome (aHUS): Analysis of a Phase III Study of Ravulizumab

Detalles Bibliográficos
Autores principales: Cammett, Tobin J, Garlo, Katherine, Millman, Ellen E, Rice, Kara, Toste, Catherine M, Faas, Susan J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10008233/
https://www.ncbi.nlm.nih.gov/pubmed/36870041
http://dx.doi.org/10.1007/s40291-023-00643-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10008233/
https://www.ncbi.nlm.nih.gov/pubmed/36870041
http://dx.doi.org/10.1007/s40291-023-00643-4

Ejemplares similares